494 related articles for article (PubMed ID: 20518791)
1. Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease.
Kaneki E; Kobayashi H; Hirakawa T; Matsuda T; Kato H; Wake N
Cancer Sci; 2010 Jul; 101(7):1717-21. PubMed ID: 20518791
[TBL] [Abstract][Full Text] [Related]
2. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
3. Management of postmolar gestational trophoblastic disease with methotrexate and folinic acid: 15 years of experience.
Sekharan PK; Sreedevi NS; Radhadevi VP; Beegam R; Raghavan J; Guhan B
J Reprod Med; 2006 Oct; 51(10):835-40. PubMed ID: 17086813
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a new diagnostic method for hydropic villi by using TSSC3 antibody.
Wake N; Takao T; Asanoma K; Kato H
J Obstet Gynaecol Res; 2013 Jul; 39(7):1230-5. PubMed ID: 23803005
[TBL] [Abstract][Full Text] [Related]
5. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
Niemann I; Hansen ES; Sunde L
Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity in the origin of recurrent complete hydatidiform moles: not all women with multiple molar pregnancies have biparental moles.
van der Smagt JJ; Scheenjes E; Kremer JA; Hennekam FA; Fisher RA
BJOG; 2006 Jun; 113(6):725-8. PubMed ID: 16709217
[TBL] [Abstract][Full Text] [Related]
7. [The propensity to malignancy of dispermic, heterozygous moles].
Hashimoto M
Hokkaido Igaku Zasshi; 1987 Jul; 62(4):564-72. PubMed ID: 2960601
[TBL] [Abstract][Full Text] [Related]
8. Prevention of postmolar gestational trophoblastic neoplasia using prophylactic single bolus dose of actinomycin D in high-risk hydatidiform mole: a simple, effective, secure and low-cost approach without adverse effects on compliance to general follow-up or subsequent treatment.
Uberti EM; Fajardo Mdo C; da Cunha AG; Rosa MW; Ayub AC; Graudenz Mda S; Schmid H
Gynecol Oncol; 2009 Aug; 114(2):299-305. PubMed ID: 19427681
[TBL] [Abstract][Full Text] [Related]
9. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
[TBL] [Abstract][Full Text] [Related]
10. Malignant potential of homozygous and heterozygous complete moles.
Wake N; Seki T; Fujita H; Okubo H; Sakai K; Okuyama K; Hayashi H; Shiina Y; Sato H; Kuroda M
Cancer Res; 1984 Mar; 44(3):1226-30. PubMed ID: 6318983
[TBL] [Abstract][Full Text] [Related]
11. Expression of maspin in gestational trophoblastic disease.
Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF
Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752
[TBL] [Abstract][Full Text] [Related]
12. Gestational trophoblastic disease in Tunisia.
Mourali M; Fkih C; Essoussi-Chikhaoui J; Ben Haj Hassine A; Binous N; Ben Zineb N; Boussen H
Tunis Med; 2008 Jul; 86(7):665-9. PubMed ID: 19472728
[TBL] [Abstract][Full Text] [Related]
13. Single-dose actinomycin D: Efficacy in the prophylaxis of postmolar gestational trophoblastic neoplasia in adolescents with high-risk hydatidiform mole.
Uberti EM; Diestel MC; Guimarães FE; De Nápoli G; Schmid H
Gynecol Oncol; 2006 Aug; 102(2):325-32. PubMed ID: 16476471
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes.
Khawajkie Y; Mechtouf N; Nguyen NMP; Rahimi K; Breguet M; Arseneau J; Ronnett BM; Hoffner L; Lazure F; Arnaud M; Peers F; Tan L; Rafea BA; Aguinaga M; Horowitz NS; Ao A; Tan SL; Brown R; Buckett W; Surti U; Hovanes K; Sahoo T; Sauthier P; Slim R
Mod Pathol; 2020 May; 33(5):880-892. PubMed ID: 31857680
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease.
Zheng XZ; Qin XY; Chen SW; Wang P; Zhan Y; Zhong PP; Buza N; Jin YL; Wu BQ; Hui P
Mod Pathol; 2020 Oct; 33(10):1979-1988. PubMed ID: 32404958
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of gestational trophoblastic disease. A single institution experience.
Khashoggi TY
Saudi Med J; 2003 Dec; 24(12):1329-33. PubMed ID: 14710278
[TBL] [Abstract][Full Text] [Related]
17. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K
J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
[TBL] [Abstract][Full Text] [Related]
18. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis.
Cheung AN; Khoo US; Lai CY; Chan KY; Xue WC; Cheng DK; Chiu PM; Tsao SW; Ngan HY
Cancer; 2004 Apr; 100(7):1411-7. PubMed ID: 15042675
[TBL] [Abstract][Full Text] [Related]
19. Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses.
Steller MA; Genest DR; Bernstein MR; Lage JM; Goldstein DP; Berkowitz RS
J Reprod Med; 1994 Mar; 39(3):147-54. PubMed ID: 8035369
[TBL] [Abstract][Full Text] [Related]
20. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2--Genetics.
Fisher RA; Paradinas FJ; Soteriou BA; Foskett M; Newlands ES
J Pathol; 1997 Feb; 181(2):189-95. PubMed ID: 9120724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
